Mounjaro dosage is the weekly tirzepatide schedule in Section 2 of the FDA label: 2.5 mg to start, rising in 2.5 mg steps to a maximum of 15 mg for adults.
Every Mounjaro dose step
| Dose | Earliest point to use it | Note |
|---|---|---|
| 2.5 mg | Weeks 1 to 4 | Where everyone starts [1] |
| 5 mg | 4 or more weeks on 2.5 mg | When more blood sugar control is needed [1] |
| 7.5 mg | 4 or more weeks on 5 mg | Same rule [1] |
| 10 mg | 4 or more weeks on 7.5 mg | Top dose for children 10+ [1] |
| 12.5 mg | 4 or more weeks on 10 mg | Adults only [1] |
| 15 mg | 4 or more weeks on 12.5 mg | Top dose for adults [1] |
No label path starts at 5 mg, and none moves up after just 2 weeks: each step waits at least 4 weeks [1]. The label does not lay out a schedule for stepping down, so ask your prescriber if side effects are hard to live with. "Best dose for weight loss" has no answer on this label, because weight loss is not a labeled use of Mounjaro [1]; the weight-management schedule is on Zepbound dosage. Semaglutide's diabetes schedule is on Ozempic dosage.
Does a higher dose mean more weight loss?
In SURMOUNT-1, which tested tirzepatide as Zepbound in adults without diabetes, average weight change at 72 weeks was -15.0% on 5 mg, -19.5% on 10 mg and -20.9% on 15 mg [3]. In SURPASS-1, a Mounjaro diabetes trial, average A1C drops were close across doses (1.7 to 1.8 points), while average weight loss grew from 6.3 kg on 5 mg to 7.8 kg on 15 mg [1]. Nausea climbed with dose as well, from 12% on 5 mg to 18% on 15 mg [1]; the rest of the list is on Mounjaro side effects. These are group averages, and reaching 15 mg does not promise further loss. See Mounjaro results.
Pens, KwikPens and vials
| Device | Doses per device | Volume per dose | Strengths |
|---|---|---|---|
| Single-dose pen or single-dose vial | 1 | 0.5 mL | 2.5, 5, 7.5, 10, 12.5 or 15 mg |
| Single-patient-use KwikPen | 4 | 0.6 mL | 2.5 to 15 mg per dose |
| Multi-dose vial | 4 | 0.6 mL | 2.5 to 15 mg per dose |
A single-dose pen delivers one complete weekly dose. Using two lower-strength pens to build a bigger dose, or splitting one pen, is not described in the label [1]. The KwikPen carries four weekly doses. It is for one patient only, even with a new needle, and the label does not recommend it for self-injection by people with impaired vision or for self-use by children [2]. If you use a vial, you need a syringe able to measure 0.5 mL or 0.6 mL and a fresh syringe and needle every time [2].
A common search is how many units make 5 mg. With compounded tirzepatide in vials, the answer depends on the concentration on the pharmacy label. Go by your prescriber's instructions and that label, and check with your pharmacist. Compounded tirzepatide is not FDA-approved, and FDA does not review it for safety, effectiveness or quality [8]. FDA declared the tirzepatide shortage over on December 19, 2024 [4]. See compounded tirzepatide.
Late doses and changing your day
- Up to 4 days (96 hours) late, give the missed dose. More than 4 days late, leave it out and use your usual day [1].
- A new dosing day works if 3 days (72 hours) or more separate the two doses [1].
- One shot a week, at any hour, with or without food [1].
- Insulin users give it as a separate shot; the two are never mixed [1].
Dose safety
Missing a week is never a reason to inject two doses. When Mounjaro is added to insulin or a sulfonylurea, the prescriber may cut those doses to lower the chance of a low [1]. Mounjaro can make birth control pills work less well, so the label calls for a non-oral or backup method for 4 weeks after the first dose and after every increase [1]; other interactions are on Mounjaro interactions. Severe stomach pain that will not stop means stop the drug and call [1]. For trouble breathing, call 911.
Price by dose
Lilly lists a 28-day box of four Mounjaro pens at $1,112.16 [5]. Lilly's savings card can bring that to $25 when a commercial plan covers the drug, or to as low as $499 a month when a commercial plan does not; it excludes uninsured buyers and people with government coverage, and it ends December 31, 2026 [6]. For self-pay comparison, LillyDirect sells Zepbound from $299 a month at 2.5 mg and $399 at 5 mg [7]. All prices were checked October 17, 2026. See Mounjaro cost and Zepbound cost.
Shot steps are on how to use Mounjaro.
Questions people ask
What is the maximum Mounjaro dose?
15 mg once a week for adults, and 10 mg once a week for children 10 and older [1].
What dose does Mounjaro start at?
2.5 mg, injected once a week [1].
What strengths does Mounjaro come in?
2.5, 5, 7.5, 10, 12.5 and 15 mg [2].
When does the Mounjaro dose go up?
By 2.5 mg at a time, once you have been on the current dose for at least 4 weeks and need more blood sugar control [1].
Can the Mounjaro dose go up after 2 weeks?
Not under the label. Each step comes after at least 4 weeks on the current dose [1].
How late can a missed Mounjaro dose be given?
Up to 4 days (96 hours). After that, skip it and take the next one on your usual day [1].
How often is Mounjaro injected?
Once a week, at any hour, with or without food [1].
How many doses does a Mounjaro pen hold?
One for a single-dose pen. Four weekly doses for a KwikPen [2].
Which Mounjaro dose is best for weight loss?
Mounjaro has no labeled weight-loss dose. Zepbound, the same medicine, lists 5, 10 or 15 mg weekly as maintenance doses for weight [2].
Sources
8 cited
- Mounjaro (tirzepatide) injection prescribing information. DailyMed, U.S. National Library of Medicine, Aug 2026.
- Zepbound (tirzepatide) injection prescribing information. DailyMed, U.S. National Library of Medicine, Aug 2026.
- Zepbound prescribing information, NDA 217806 (PDF). U.S. Food and Drug Administration, Apr 2026.
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. U.S. Food and Drug Administration, Apr 1, 2026.
- Mounjaro frequently asked questions. Eli Lilly and Company, Oct 17, 2026.
- Mounjaro savings resources. Eli Lilly and Company, Oct 17, 2026.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company, Oct 17, 2026.
- Compounding and the FDA: questions and answers. U.S. Food and Drug Administration, 2025-09-16 (accessed 2026-10-17).
This page is general information, not medical advice. Talk with a licensed clinician about your own care.